Traumatic brain injury is a major risk factor for acquired epilepsies and understanding the 8 mechanisms underlying the early pathophysiology could yield viable therapeutic targets. 9
1 0 0 recorded and analyzed as detailed previously (12) . CP-AMPAR current was recorded at -60 mV 1 0 1 and +40 mV holding potential in the presence of SR95531 (10µM) and D-APV (50 µM). The cell surface proteins of hippocampus were isolated using Pierce cell surface protein isolation groups and the extracted proteins as well as total proteins were used for western blotting 1 1 0 analysis. Western blots were performed as described previously (12) . Membranes were then 1 1 1 washed and incubated overnight at 4°C with the corresponding primary and secondary 1 1 2 antibodies. Chemiluminescent detection was performed using FluoroChem 8800, and images 1 1 3 were quantified using Image-J (NIH). Surface protein expression was normalized to 1 1 4 corresponding total protein levels and total protein levels were normalized and normalized to was negligible compared to the β -actin levels in the total protein and likely reflect proteins 1 1 7 associated with intracellular membranes. All antibodies used in the study are in Supplementary 1 1 8 seizures with shorter latency following low-dose KA injection demonstrating post-traumatic 2 3 8 enhancement of seizure susceptibility. In a small cohort, we monitored animals for spontaneous 2 3 9
seizures after brain injury. In 30-40-hour simultaneous video-and surface EEG recordings from 2 4 0 rats 12-15 weeks after sham or FPI, none of the sham rats (n=9) showed electrographic seizures, 2 4 1 while spontaneous electrographic and behavioral seizures were observed in 8 of 13 FPI rats 2 4 2 (~62%, Fig. 4a-d ). In rats with spontaneous seizures the average seizure severity was Racine To transition our findings on TLR4 modulation of excitability in ex vivo slices to in vivo, we 2 4 6
examined whether systemic TLR4 antagonism could modify dentate excitability one week after 2 4 7
injury. Sham and FPI rats were treated with CLI-095 (0.5mg/kg, s.c. for 3 days) starting 20-24 2 4 8 hours after injury and dentate excitability was examined in hippocampal slices 6-8 days later. As with acute incubations, CLI-095 treatment in vivo increased dentate excitability in sham-injured 2 5 0 rats, while effectively suppressing excitability after FPI ( Fig. 5a-c) . These data justify the use of 2 5 1 in vivo treatments in evaluating the effect of TLR4 signaling on early dentate excitability and 2 5 2 epileptogenesis after brain injury. Although the post-injury increase in dentate excitability is postulated to underlie a long-term increased risk for epilepsy (4, 5, 40), this association remains untested. Since blocking TLR4 2 5 5 reduces excitability after injury and increases excitability in uninjured rats, TLR4 antagonism 2 5 6
provides an opportunity to test the link between early excitability and subsequent risk for seizures. Rats were treated with systemic CLI-095 (0.5mg/kg) or saline once daily for 3 days 2 5 8 starting 24 hours after sham or brain injury, when hippocampal TLR4 levels were found to be 2 5 9 maximal (12, 41). As expected, saline-treated injured rats had a shorter latency to KA-induced prolonging seizure latency in FPI rats at one-month and three months post-FPI ( Fig. 5f -g). Mechanistically, the data reveal that the risk for seizures is driven by early changes in dentate 2 6 4 excitability. Translationally, these results show that transiently blocking TLR4 early after brain injury has the potential to prevent post-traumatic epileptogenesis. Early focal TLR4 antagonism is sufficient reduce post-traumatic increases in seizure 2 6 7 susceptibility while delayed treatment is ineffective.
6 8
To probe the association between hippocampal TLR4 signaling and epileptogenesis, we adopted 2 6 9 a focal TLR4 antagonist treatment. Ipsilateral bolus hippocampal injection of LPS-RSU 2 7 0 (2mg/ml) 24 hours after FPI/sham led to decreased latency to KA-evoked seizures in sham rats 2 7 1 and eliminated seizures altogether in FPI rats when examined one and three months after brain 2 7 2 injury ( Fig. 6a, b, d ). Hippocampal LPS-RSU treatment enhanced seizure severity in controls and 2 7 3 reduced seizure severity in FPI rats at one and three months after FPI/sham. (Fig. 6c, e ). Thus, 2 7 4 local suppression of TLR4 in the injured hippocampus and its modification of early dentate 2 7 5 excitability can predict long-term seizure susceptibility. Interestingly, analysis of mortality among experimental animals revealed that sham-injured rats 2 7 7 treated with TLR4 antagonists had increased mortality while post-traumatic rats treated with 2 7 8 TLR4 antagonists showed lower mortality (% mortality between one week after treatment and The salience of the early period of excitability to seizure susceptibility, was tested by delivering 6f-h). Conversely, delayed LPS-RSU treatment failed to reduce seizure susceptibility after FPI 2 9 1 ( Fig. 6f-h ), highlighting the importance of the early post-injury increases in dentate network 2 9 2 excitability in long-term seizure risk. TLR4 antagonism reduces cellular inflammation following FPI without altering 2 9 5 inflammatory milieu in controls.
9 6
Since TLR4 signaling leads to cellular inflammation, prior studies have attributed beneficial 2 9 7 effects of blocking TLR4 after brain trauma to reducing inflammatory responses (42). To test 2 9 8 whether inflammatory responses could mediate the divergent effects of TLR4 antagonists on 2 9 9 seizure susceptibility, we examined the inflammatory responses in hippocampal tissue obtained 3 0 0 from saline/CLI-095-treated rats three days after sham/FPI. In western blots, CLI-095 3 0 1 significantly reduced hippocampal expression of TLR4, GFAP and Iba1 in the injured brain Tukey's post hoc test, n= 3 each). TLR4 expression in FPI rats treated with CLI-095 one day test, n= 3 each). Curiously, GFAP protein levels were highly variable after FPI, increasing in 3 1 1 some and decreasing in others and was not significantly different between groups (FPI-saline However, GFAP protein levels in FPI-CLI group trended to decrease in FPI-saline group one- injury. Surface expression of GluA1 was not different between saline treated sham and FPI 3 1 8 groups (surface/total GluA1 ratio normalized to sham-saline: sham-saline: 1.00±0.0; FPI-Saline:
1.12±0.29, p=0.94, n=3 each). Additionally, early CLI-095 treatment did not alter surface-
expression of GluA1 tested one month after FPI (surface/total GluA1 ratio normalized to sham-3 2 1 saline: FPI-CLI 1.23±0.43, p=0.96, n=3 each). However, total GluA1 levels showed a significant (43) and demonstrates that early treatment with CLI-095 reduces a potential molecular substrate 3 2 8
for persistent posttraumatic increase in excitability.
2 9
Flow cytometry to quantify the cellular inflammation in the hippocampus was performed three 3 3 0 days after sham/FPI followed by treatments. The data revealed a significant increase in treatment on histopathology, we examined the dentate hilus for neuronal loss one week after To test whether the ability of TLR4 antagonists to suppress excitability can influence post-injury presence of TLR4 antagonists in slices from brain-injured rats. Afferent-evoked granule cell 3 5 0 AMPAR current charge transfer was enhanced one week after brain injury ( Fig.8a -c) and Notably, TLR4 modulation of CP-AMPAR currents was observed in isolated neuronal cultures, contribution. It is attractive to speculate that TLR4 recruits glia-independent signals to promote 3 7 6
GluA1 trafficking and surface expression in the injured brain. These results constitute the first In contrast to its effects after injury, TLR4 antagonists enhanced network excitability in controls 3 8 0 (12) . in contrast to effects on excitability, TLR4 antagonists suppressed the post-traumatic effects of TLR4 signaling on excitability and seizure susceptibility in controls and after injury. These findings suggest that a distinct TLR4 signaling pathway is utilized after injury. Overall,
analysis of the short-term effects of TLR4 signaling revealed constitutive suppression of of effects on the inflammatory milieu, manipulations that increase in hippocampal dentate 4 0 5 excitability drive long-term increased risk for epilepsy. Importantly, the aberrant neuronal TLR4-4 0 6 mediated increase in CP-AMPAR may be targeted after brain trauma to prevent epileptogenesis. There is growing evidence for interactions between inflammatory signaling and neuronal neuronal CP-AMPAR currents, independent of glia, identifies a novel mechanism by which 4 2 0 TLR4 promotes excitotoxic damage and epileptogenesis independent of inflammatory signaling. Our findings uncover a unique neuronal axis of TLR4 signaling similar to reports in Major The contribution of glial mediators to TLR4 regulation of neuronal excitability has been 4 3 7 identified in earlier studies (10, 13, 49). Our findings in neuronal cultures demonstrate that glial previously reported a ~40% increase in granule cell peak AMPAR currents in slices from brain 4 4 2 injured rats, which was abolished by incubation in TLR4 blockers (12) . Our finding that blocking suggesting that an increase in CP-AMPARs may drive excitotoxic neuronal loss and 4 5 0 epileptogenesis after brain injury. Similarly, TLR4 also augments AMPAR currents in mossy 4 5 1 cells after FPI (12) and enhanced mossy cell activity drives an increase in granule cell AMPAR 4 5 2 charge transfer after brain injury (33). Thus, the rapid TLR4 regulation of AMPAR currents likely plays an important role in increasing excitability shortly after brain injury. In contrast to 4 5 4 the lack of increase in total GluA1 levels one week after FPI, hippocampal total GluA1 4 5 5 expression appears increased one month after FPI suggesting that the mechanisms underlying We find that blocking TLR4 signaling in uninjured rats promotes neuronal loss in the dentate 4 6 1 hilus and raises the concern that systemic TLR4 antagonists may contribute to cell loss in 4 6 2 uninjured brain regions and compromise circuit function. These findings underscore the need to Curiously, AMPAR current rectification in cultured neurons from WT mice resembled the 4 6 6 injured brain while those from TLR4 -/mice were similar to the uninjured brain. This 4 6 7 demonstration that TLR4 is necessary for AMPAR current rectification in cultured neurons 4 6 8 provides a mechanism for the previously reported developmental increase in CP-AMPARs in 4 6 9 neuronal cultures (36). The parallels between TLR4 effects on AMPAR currents in cultured 4 7 0 neurons and the injured brain suggest that the process of generating cultures may impart an 4 7 1 "injured" AMPAR phenotype.
after injury limits seizure susceptibility, delayed treatment is ineffective in reducing seizure 4 9 0 susceptibility ( Fig. 6d-f ), validating the critical role for early network excitability and a potential 4 9 1 "therapeutic window" in post-traumatic epileptogenesis.
9 2
Traumatic brain injury is a major risk factor for epilepsy among young adults. Consistent with FPI. It is possible that strain differences, use of younger juvenile rats which are more susceptible 4 9 5 to adverse effects of brain injury (63), implementation of injury on the day after surgery to administered 24 hours after brain injury presents an opportunity to target TLR4 to prevent post- inhibition contributes to increase in dentate semilunar granule cell excitability after brain receptor antagonist-induced dopamine release in the rat nucleus accumbens shell. GluA2 (j) expression normalized to total GluA1 and GluA2 respectively and total GluA1 (k) Schematic of timeline for in vivo injury followed by electrode implantation and low-does Kainic stimulus to the perforant path in slices from sham (above) and brain injured (below) rats treated recordings in sham and brain injured rats treated with vehicle or CLI-095 (0.5mg/kg). 
